Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2031250418) titled 'Phase 3 single arm, open study on vYF in adults' on Oct. 8.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), uncontrolled control, single assignment, prevention purpose
Primary Sponsor: Obara Kentaro
Condition:
Yellow fever
Intervention:
Intervention: YF vaccine (live) (vYF vaccine)
Pharmaceutical form: Powder and diluent for suspension for injection
Route of administration: Subcutaneous
Study Arm:
- Experimental: vYF
One single dose of vYF will be administered subcutaneously at the 1st visit....
Recruitment Status: Recruiting
Phase: 3
Date of First Enrollment: ...